Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Retinoid Receptors in Gastric Cancer: Expression and Influence on Prognosis

  • Hu, Kong-Wang (Department of General Surgery, the First Hospital of Anhui Medical University) ;
  • Chen, Fei-Hu (School of Pharmacology, Anhui Medical University) ;
  • Ge, Jin-Fang (School of Pharmacology, Anhui Medical University) ;
  • Cao, Li-Yu (Department of Pathology, the First Hospital of Anhui Medical University) ;
  • Li, Hao (Department of Pathology, the First Hospital of Anhui Medical University)
  • Published : 2012.05.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Gastric cancer is frequently lethal despite aggressive multimodal therapies, and new treatment approaches are therefore needed. Retinoids are potential candidate drugs: they prevent cell differentiation, proliferation and malignant transformation in gastric cancer cell lines. They interact with nuclear retinoid receptors (the retinoic acid receptors [RARs] and retinoid X receptors [RXRs]), which function as transcription factors, each with three subclasses, ${\alpha}$, ${\beta}$ and ${\gamma}$. At present, little is known about retinoid expression and influence on prognosis in gastric cancers. Patients and Methods: We retrospectively analyzed the expression of the subtypes RARa, $RAR{\beta}$, $RAR{\gamma}$, RXRa, $RXR{\beta}$, $RXR{\gamma}$ by immunohistochemistry in 147 gastric cancers and 51 normal gastric epithelium tissues for whom clinical follow-up data were available and correlated the results with clinical characteristics. In addition, we quantified the expression of retinoid receptor mRNA using real-time PCR (RT-PCR) in another 6 gastric adenocarcinoma and 3 normal gastric tissues. From 2008 to 2010, 80 patients with gastric cancers were enrolled onto therapy with all-trans-retinoic acid (ATRA). Results: RARa, $RAR{\beta}$, $RAR{\gamma}$ and $RXR{\gamma}$ positively correlated with each other (p < 0.001) and demonstrated significantly lower levels in the carcinoma tissue sections (p < 0.01), with lower $RAR{\beta}$, $RAR{\gamma}$ and RXRa expression significantly related to advanced stages (p < =0.01). Tumors with poor histopathologic grade had lower levels of RARa and $RAR{\beta}$ in different histological types of gastric carcinoma (p < 0.01). Patients whose tumors exhibited low levels of RARa expression had significantly lower overall survival compared with patients who had higher expression levels of this receptor (p < 0.001, HR=0.42, 95.0% CI 0.24-0.73), and patients undergoing ATRA treatment had significantly longer median survival times (p = 0.007, HR=0.41, 95.0% CI 0.21-0.80). Conclusions: Retinoic acid receptors are frequently expressed in epithelial gastric cancer with a decreased tendency of expression and RARa may be an indicator of a positive prognosis. This study provides a molecular basis for the therapeutic use of retinoids against gastric cancer.

Keywords

References

  1. Abu J, Batuwangala M, Herbert K, Symonds P (2005). Retinoic acid and retinoid receptors: potential chemopreventive and therapeutic role in cervical cancer. Lancet Oncol, 6, 712-20. https://doi.org/10.1016/S1470-2045(05)70319-3
  2. Aebi S, Kroning R, Cenni B, et al (1997). All-trans retinoic acid enhances cisplatin-induced apoptosis in human ovarian adenocarcinoma and in squamous head and neck cancer cells. Clin Cancer Res, 3, 2033-8.
  3. Altucci L, Gronemeyer H (2001). The promise of retinoids to fight against cancer. Nat Rev Cancer, 1, 181-93. https://doi.org/10.1038/35106036
  4. Ben Ayed-Guerfali D, Benhaj K, Khabir A, et al (2011). Hypermethylation of tumor-related genes in Tunisian patients with gastric carcinoma: clinical and biological significance. J Surg Oncol, 103, 687-94. https://doi.org/10.1002/jso.21875
  5. Chakravarti N, Mathur M, Bahadur S Kumar Shukla N, Ralhan R (2003). Retinoic acid receptor alpha as a prognostic indicator in oral squamous cell carcinoma. Int J Cancer, 103, 544-9. https://doi.org/10.1002/ijc.10819
  6. Chao TY, Jiang SY, Shyu RY, Yeh MY, Chu TM (1997). Alltrans retinoic acid decreases susceptibility of a gastric cancer cell line to lymphokine-activated killer cytotoxicity. Br J Cancer, 75, 1284-90. https://doi.org/10.1038/bjc.1997.218
  7. Coelho SM, Vaisman M, Carvalho DP (2005). Tumour redifferentiation effect of retinoic acid: a novel therapeutic approach for advanced thyroid cancer. Curr Pharm Des, 11, 2525-31. https://doi.org/10.2174/1381612054367490
  8. Cox DR (1972). Regression models and life tables (with discussion). J R Stat Soc B, 34, 187-220.
  9. Crew KD, Neugut AI (2006). Epidemiology of gastric cancer. World J Gastroenterol, 12, 354-62. https://doi.org/10.3748/wjg.v12.i3.354
  10. Crowe DL, Kim R, Chandraratna RA (2003). Retinoic acid differentially regulates cancer cell proliferation via dosedependent modulation of the mitogen-activated protein kinase pathway. Mol Cancer Res, 1, 532-40.
  11. Cunningham SC, Kamangar F, Kim MP, et al (2005). Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution. J Gastrointest Surg, 9, 718-25. https://doi.org/10.1016/j.gassur.2004.12.002
  12. Deng J, Liang H, Sun D, Wang D, Pan Y (2010). Suitability of 7th UICC N stage for predicting the overall survival of gastric cancer patients after curative resection in China. Ann Surg Oncol, 17, 1259-66. https://doi.org/10.1245/s10434-010-0939-x
  13. Edge SB, Byrd DR, Compton CC, et al (2010). editors. AJCC cancer staging manual. 7th edition ed. NewYork, NY: Springer.
  14. Evans R (1998). The steroid and thyroid hormone receptor superfamily. Science, 13, 889-95.
  15. Farol LT, Hymes KB (2004). Bexarotene: a clinical review. Expert Rev Anticancer Ther, 4, 180-8. https://doi.org/10.1586/14737140.4.2.180
  16. Garattini E, Gianni M, Terao M (2007). Cytodifferentiation by retinoids, a novel therapeutic option in oncology: rational combinations with other therapeutic agents. Vitam Horm, 75, 301-54. https://doi.org/10.1016/S0083-6729(06)75012-9
  17. Gobbi PG, Villano L, Pozzoli D, et al (2011). Improving the AJCC/TNM classification for use in early gastric cancer. J Gastrointest Surg, 15, 935-41. https://doi.org/10.1007/s11605-011-1522-x
  18. Gunderson LL, Sosin H (1982). Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys, 8, 1-11. https://doi.org/10.1016/0360-3016(82)90185-7
  19. Gyftopoulos K, Perimenis P, Sotiropoulou-Bonikou G et al (2000). Immunohistochemical detection of retinoic acid receptor-alpha in prostate carcinoma: correlation with proliferative activity and tumor grade. Int Urol Nephrol, 32, 263-9. https://doi.org/10.1023/A:1007126332651
  20. Hamilton SR, Aaltonen LA (2000). Pathology and genetics. Tumors of the digestive system. Geneva: WHO Press pp 1-314.
  21. Hayashi K, Yokozaki H, Goodison S, et al (2001). Inactivation of retinoic acid receptor beta by promoter CpG hypermethylation in gastric cancer. Differentiation, 68, 13-21. https://doi.org/10.1046/j.1432-0436.2001.068001013.x
  22. Horn TL, Torres KE, Naylor JM, et al (2007). Subchronic toxicity and toxicogenomic evaluation of tamoxifen citrate + bexarotene in female rats. Toxicol Sci, 99, 612-27. https://doi.org/10.1093/toxsci/kfm181
  23. Hsu SM, Reiner L, Fanger H (1981). Use of avidin-biotinperoxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem, 29, 577-80. https://doi.org/10.1177/29.4.6166661
  24. Huang SL, Shyu RY, Yeh MY, Jiang SY (2002). The retinoidinducible gene I: effect on apoptosis and mitogen-activated kinase signal pathways. Anticancer Res, 22, 799-804.
  25. Jiang CG, Wang ZN, Sun Z, et al (2011). Clinicopathologic characteristics and prognosis of signet ring cell carcinoma of the stomach: results from a Chinese mono-institutional study. J Surg Oncol, 103, 700-3. https://doi.org/10.1002/jso.21878
  26. Jiang SY, Shen SR, Shyu RY, et al (1999). Expression of nuclear retinoid receptors in normal, premalignant and malignant gastric tissues determined by in situ hybridization. Br J Cancer, 80, 206-14. https://doi.org/10.1038/sj.bjc.6690340
  27. Jozan S, Lafon C (1996). Enhancement of cisplatin cytotoxicity by all-trans retinoic acid in a human ovarian carcinoma cell line (OVCCR1) is characterized by apoptosis. Proc Am Assoc Cancer Res, 37, 414.
  28. Jozan S, Paute S, Courtade-Saidi M et al (2002). All trans retinoic acid enhances CDDP-induced apoptosis: modulation of the CDDP effect on cell cycle progression. Int J Oncol, 20, 1289-95.
  29. Kaplan EL, Meier P (1958). Nonparametric estimations from incomplete observations. J Am Stat Assoc, 53, 457-81. https://doi.org/10.1080/01621459.1958.10501452
  30. Karam SM, Hassan WM, John R (2005). Expression of retinoid receptors in multiple cell lineages in the gastric mucosae of mice and humans. J Gastroenterol Hepatol, 20, 1892-9. https://doi.org/10.1111/j.1440-1746.2005.04064.x
  31. Khedmat H, Panahian M, Mashahdian M, Rajabpour MV, Zendehdel K (2011). Prognostic factors and survival in stomach cancer - analysis of 15 years of data from a referral hospital in iran and evaluation of international variation. Onkologie, 34, 178-82. https://doi.org/10.1159/000327007
  32. Khuri FR, Lippman SM, Spitz MR, Lotan R, Hong WK (1997). Molecular epidemiology and retinoid chemoprevention of head and neck cancer. J Natl Cancer Inst, 89, 199-211. https://doi.org/10.1093/jnci/89.3.199
  33. Kim JH, Choi YK, Kwon HJ et al (2004). Downregulation of gelsolin and retinoic acid receptor beta expression in gastric cancer tissues through histone deacetylase 1. J Gastroenterol Hepatol, 19, 218-24. https://doi.org/10.1111/j.1440-1746.2004.03336.x
  34. Koike H, Ichikawa D, Ikoma H, et al (2005). Comparison of serum aberrant methylation and conventional tumor markers in gastric cancer patients. Hepatogastroenterology, 52, 1293-6.
  35. Kunisaki C, Ishino J, Nakajima S, et al (2006). Outcomes of mass screening for gastric carcinoma. Ann Surg Oncol, 13, 221-8. https://doi.org/10.1245/ASO.2006.04.028
  36. Lin XF, Zhao BX, Chen HZ, et al (2004). RXRalpha acts as a carrier for TR3 nuclear export in a 9-cis retinoic aciddependent manner in gastric cancer cells. J Cell Sci, 117, 5609-21. https://doi.org/10.1242/jcs.01474
  37. Lippman SM, Benner SE, Hong WK (1994). Cancer chemoprevention. J Clin Oncol, 12, 851-73. https://doi.org/10.1200/JCO.1994.12.4.851
  38. Lippman SM, Lee JJ, Karp DD et al (2001). Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. J Natl Cancer Inst, 93, 605-18. https://doi.org/10.1093/jnci/93.8.605
  39. Liu G, Wu M, Levi G, Ferrari N (1998). Inhibition of cancer cell growth by all-trans retinoic acid and its analog N-(4- hydroxyphenyl) retinamide: a possible mechanism of action via regulation of retinoid receptors expression. Int J Cancer, 78, 248-54. https://doi.org/10.1002/(SICI)1097-0215(19981005)78:2<248::AID-IJC20>3.0.CO;2-5
  40. Liu S, Wu Q, Chen ZM, Su WJ (2001). The effect pathway of retinoic acid through regulation of retinoic acid receptor alpha in gastric cancer cells. World J Gastroenterol, 7, 662-6. https://doi.org/10.3748/wjg.v7.i5.662
  41. Mangelsdorf DJ, Umesono K, Evans RM (1994). The retinoid receptors. In: Sporn MB, Roberts AB, Goodman DS, eds. The Retinoids: Biology, Chemistry, and Medicine, 2nd Edition. New York: Raven Press pp 319-50.
  42. Mantel N (1966). Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep, 50, 163-70.
  43. Mehta K (2003). Retinoids as regulators of gene transcription. J Biol Regul Homeost Agents, 17, 1-12.
  44. Msika S, Benhamiche AM, Jouve JL, Rat P, Faivre J (2000). Prognostic factors after curative resection for gastric cancer. A population-based study. Eur J Cancer, 36, 390-6. https://doi.org/10.1016/S0959-8049(99)00308-1
  45. Nehme A, Varadarajan P, Sellakumar G et al (2001). Modulation of docetaxel-induced apoptosis and cell cycle arrest by all-trans retinoic acid in prostate cancer cells. Br J Cancer, 84, 1571-6. https://doi.org/10.1054/bjoc.2001.1818
  46. Parkin DM (2001). Global cancer statistics in the year 2000. Lancet Oncol, 29, 533-43.
  47. Pasquali D, Rossi V, Bellastella G, Bellastella A, Sinisi AA (2006). Natural and synthetic retinoids in prostate cancer. Curr Pharm Des, 12, 1923-9. https://doi.org/10.2174/138161206776873554
  48. Peto R, Pike MC, Armitage P, et al (1977). Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer, 35, 1-39. https://doi.org/10.1038/bjc.1977.1
  49. Petrie K, Zelent A, Waxman S (2009). Differentiation therapy of acute myeloid leukemia: past, present and future. Curr Opin Hematol, 16, 84-91. https://doi.org/10.1097/MOH.0b013e3283257aee
  50. Pocock SJ, Simon R (1975). Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics, 31, 103-15. https://doi.org/10.2307/2529712
  51. Reynolds CP (2000). Differentiating agents in pediatric malignancies: retinoids in neuroblastoma. Curr Oncol Rep, 2, 511-8. https://doi.org/10.1007/s11912-000-0104-y
  52. Richter F, Joyce A, Fromowitz F, et al (2002). Immunohistochemical localization of the retinoic Acid receptors in human prostate. J Androl, 23, 830-8.
  53. Riecken EO, Rosewicz S (1999). Retinoids in pancreatic cancer. Ann Oncol, 4, 197-200.
  54. Sachs L (1978a). Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia. Nature, 274, 535-9. https://doi.org/10.1038/274535a0
  55. Sachs L (1978b). The differentiation of myeloid leukaemia cells:new possibilities for therapy. Br J Haematol, 40, 509-17. https://doi.org/10.1111/j.1365-2141.1978.tb05826.x
  56. Sankaranarayanan R, Mathew B (1996). Retinoids as cancerpreventive agents. IARC Sci Publ, 139, 47-59.
  57. Sanz MA, Martin G, Diaz-Mediavilla J (1998). All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med, 338, 393-4. https://doi.org/10.1056/NEJM199802053380613
  58. Scribner DR Jr, Benbrook DM (2002). Retinoids enhance cisplatin-based chemoradiation in cervical cancer cells in vitro. Gynecol Oncol, 85, 223-5. https://doi.org/10.1006/gyno.2002.6590
  59. Shutoh M, Oue N, Aung PP, et al (2005). DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinolbinding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation. Cancer, 104, 1609-19. https://doi.org/10.1002/cncr.21392
  60. Shyu RY, Jiang SY, Huang SL, et al (1995). Growth regulation by all-trans-retinoic acid and retinoic acid receptor messenger ribonucleic acids expression in gastric cancer cells. Eur J Cancer, 31A, 237-43.
  61. Soprano DR, Qin P, Soprano KJ (2004). Retinoic acid receptors and cancers. Annu Rev Nutr, 24, 201-21. https://doi.org/10.1146/annurev.nutr.24.012003.132407
  62. Sun SY, Lotan R (2002). Retinoids and their receptors in cancer development and chemoprevention. Crit Rev Oncol Hematol, 41, 41-5. https://doi.org/10.1016/S1040-8428(01)00144-5
  63. Tanaka T, De Luca LM (2009). Therapeutic potential of "rexinoids" in cancer prevention and treatment. Cancer Res, 69, 4945-7. https://doi.org/10.1158/0008-5472.CAN-08-4407
  64. van der Leede BM, Geertzema J, Vroom TM et al (1996). Immunohistochemical analysis of retinoic acid receptoralpha in human breast tumors: retinoic acid receptor-alpha expression correlates with proliferative activity. Am J Pathol, 148, 1905-14.
  65. Wang Q, Wieder R (2004). All-trans retinoic acid potentiates Taxotere-induced cell death mediated by Jun N-terminal kinase in breast cancer cells. Oncogene, 23, 426-33. https://doi.org/10.1038/sj.onc.1207040
  66. Wang Q, Yang W, Uytingco MS, Christakos S, Wieder R (2000). 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death. Cancer Res, 60, 2040-8.
  67. White SJ, Freedman LS (1978). Allocation of patients to treatment groups in a controlled clinical study. Br J Cancer, 37, 849-57. https://doi.org/10.1038/bjc.1978.124
  68. Wu Q, Chen Z, Liu S (2000). Mechanism of retinoic acid receptor alpha-mediated growth inhibition of gastric cancer cells by all-trans retinoic acid. Zhonghua Zhong Liu Za Zhi, 22, 195-7.
  69. Wu Q, Chen ZM, Su WJ (2002). Anticancer effect of retinoic acid via AP-1 activity repression is mediated by retinoic acid receptor alpha and beta in gastric cancer cells. Int J Biochem Cell Biol, 34, 1102-14. https://doi.org/10.1016/S1357-2725(02)00030-4
  70. Wu Q, Lin XF, Ye XF, et al (2004). Ubiquitinated or sumoylated retinoic acid receptor alpha determines its characteristic and interacting model with retinoid X receptor alpha in gastric and breast cancer cells. J Mol Endocrinol, 32, 595-613. https://doi.org/10.1677/jme.0.0320595
  71. Xu RC, Zhou YH, Hu WL (2006). Inducement effect of 9-cis retinoic acid on cell cycle arrest and apoptosis of gastric carcinoma cell line MGC803 and its mechanism. Ai Zheng, 25, 1483-7.
  72. Ye X, Wu Q, Liu S, Lin X, et al (2004). Distinct role and functional mode of TR3 and RARalpha in mediating ATRAinduced signalling pathway in breast and gastric cancer cells. Int J Biochem Cell Biol, 36, 98-113. https://doi.org/10.1016/S1357-2725(03)00143-2
  73. Yoshida K, Tanabe K, Fujii D, et al (2003). Induction mechanism of apoptosis by troglitazone through peroxisome proliferatoractivated receptor-gamma in gastric carcinoma cells. Anticancer Res, 23, 267-73.
  74. Zanardi S, Serrano D, Argusti A, et al (2006). Clinical trials with retinoids for breast cancer chemoprevention. Endocr Relat Cancer, 13, 51-68. https://doi.org/10.1677/erc.1.00938

Cited by

  1. Expression of genes involved in retinoic acid biosynthesis in human gastric cancer vol.47, pp.2, 2013, https://doi.org/10.1134/S0026893313020076
  2. Bioinformatics and Gene Network Analyses of the Swine Mammary Gland Transcriptome during Late Gestation vol.7, pp.1177-9322, 2013, https://doi.org/10.4137/BBI.S12205
  3. A Novel All-trans Retinoid Acid Derivative N-(3-trifluoromethyl-phenyl)-Retinamide Inhibits Lung Adenocarcinoma A549 Cell Migration through Down-regulating Expression of Myosin Light Chain Kinase vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7687
  4. -retinoic acid to omeprazole and sucralfate therapy improves the prognosis of gastric dysplasia vol.43, pp.2, 2015, https://doi.org/10.1177/0300060514559791
  5. Human gastric epithelial cells contribute to gastric immune regulation by providing retinoic acid to dendritic cells vol.8, pp.3, 2015, https://doi.org/10.1038/mi.2014.86
  6. Combination treatment of all-trans retinoic acid (ATRA) and γ-secretase inhibitor (DAPT) cause growth inhibition and apoptosis induction in the human gastric cancer cell line vol.70, pp.2, 2018, https://doi.org/10.1007/s10616-018-0199-3